<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Intensive Care Med</journal-id>
      <journal-title-group>
        <journal-title>Intensive Care Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0342-4642</issn>
      <issn pub-type="epub">1432-1238</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21590348</article-id>
      <article-id pub-id-type="pmc">3136690</article-id>
      <article-id pub-id-type="publisher-id">2242</article-id>
      <article-id pub-id-type="doi">10.1007/s00134-011-2242-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acute renal failure due to tobramycin intoxication during selective digestive tract decontamination</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ramnarain</surname>
            <given-names>D.</given-names>
          </name>
          <address>
            <phone>+31-13-5391313</phone>
            <email>D.Ramnarain@elisabeth.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Lange</surname>
            <given-names>D. W.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meulenbelt</surname>
            <given-names>J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Division of Intensive Care Medicine, St. Elisabeth Hospital, Hilvarenbeekseweg 60, 5000 LC Tilburg, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Division Intensive Care Center, University Medical Center Utrecht, Utrecht, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>13</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2011</year>
      </pub-date>
      <volume>37</volume>
      <issue>8</issue>
      <fpage>1386</fpage>
      <lpage>1387</lpage>
      <history>
        <date date-type="accepted">
          <day>10</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Copyright jointly held by Springer and ESICM 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>A 52-year-old man was admitted to the intensive care unit (ICU) with septic shock due to pneumonia. Two months before he had an oesophago-gastrectomy because of carcinoma of the distal part of the oesophagus. The post-operative course was complicated because of ischaemic lesions in the transverse colon and suture dehiscence of the ileotransversostomy. An ileostomy and colostomy were constructed (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Schematic drawing of patient&#x2019;s changed anatomy after surgery. Resection of esophagus and stomach, replaced by a colon segment with a Roux-Y reconstruction. After suture dehiscence of the ileotransversostomy the suture was opened, transversectomy was performed because of multiple ischaemic lesions. An ileostomy and colostomy were constructed</p></caption><graphic xlink:href="134_2011_2242_Fig1_HTML" id="MO1"/></fig></p>
    <p>Apart from antibiotic treatment, he received selective decontamination of the digestive tract (SDD) as described previously by De Smet et al [<xref ref-type="bibr" rid="CR1">1</xref>]. SDD was administered four times daily as a 2% oral paste, containing amphotericin B, tobramycin and colistin. Four times daily a 10&#xA0;ml (containing 500&#xA0;mg amphotericin B, 100&#xA0;mg colistin, 80&#xA0;mg tobramycin) suspension was given nasogastrically. Additionally, twice daily a suppository (containing 500&#xA0;mg amphotericin B, 40&#xA0;mg tobramycin, 100&#xA0;mg colistin) was administered in the colostomy of the descending colon. He recovered but because of ICU-acquired weakness he needed prolonged mechanical ventilation. Thirty days after admission he became oliguric and developed renal failure with renal acidosis without further clinical signs of haemodynamic instability. His creatinine level gradually increased from 50 to 263&#xA0;&#x3BC;mol/l. Physical, laboratory and radiological examination ruled out sepsis, hypovolaemia and post-renal obstruction. Medication-induced nephrotoxicity was suspected. Serum tobramycin level was elevated (18.9&#xA0;mg/l). SDD was discontinued. After haemodialysis and veno-venous haemofiltration tobramycin levels became undetectable again. However, renal insufficiency persisted and he remained dependent on dialysis.</p>
    <p>Elevated serum tobramycin levels during SDD have been shown in patients with normal renal function and pre-existent renal insufficiency [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Several mechanisms might explain increased serum levels of non-absorbable antimicrobial agents in this patient. First, the integrity of the mucosal barrier might have been compromised by the initial sepsis causing increased permeability for tobramycin [<xref ref-type="bibr" rid="CR4">4</xref>]. Secondly, our patient was malnourished as a result of chronic illness and frequent periods of retention of enteral feeding. Malnutrition is associated with increased movements of large molecules through the paracellular tight junction in jejunal epithelia [<xref ref-type="bibr" rid="CR5">5</xref>]. Thirdly, our patient had a blinded jejunal loop which could act as reservoir for tobramycin.</p>
    <p>The amphotericin B levels were not measured but could also be increased. The nephrotoxic effect of parenteral administration of amphotericin B is well known. No other medication could explain the acute renal failure.</p>
    <p>This case indicates that patients with altered abdominal anatomy and/or perforations and/or malnutrition might be at risk to develop nephrotoxicity from SDD, especially when SDD is administered via several routes. Besides the current debate about the effects of SDD on antibiotic resistance, no complications of tobramycin-related toxicity are reported in more than 50 randomized controlled trials. Future studies on SDD should also incorporate such safety analyses.</p>
  </body>
  <back>
    <ack>
      <title>Open Access</title>
      <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smet</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kluytmans</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Mascini</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Benus</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Werf</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Hoeven</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Pickkers</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bogaers-Hofman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Meer</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Bernards</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Kuijper</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Joore</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Leverstein-van Hall</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bindels</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Jansz</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Wesselink</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Jongh</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Dennesen</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Asselt</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Velde</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Frenay</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Kaasjager</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Van</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Thijsen</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Kluge</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Pauw</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Vries</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Kaan</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Arends</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Aarts</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Sturm</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Harinck</surname>
              <given-names>HI</given-names>
            </name>
            <name>
              <surname>Voss</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uijtendaal</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Blok</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Thieme Groen</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pouw</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Kalkman</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Bonten</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Decontamination of the digestive tract and oropharynx in ICU patients</article-title>
          <source>N Engl J Med</source>
          <year>2009</year>
          <volume>360</volume>
          <fpage>20</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa0800394</pub-id>
          <pub-id pub-id-type="pmid">19118302</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mol</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kan</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Jonge</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Systemic tobramycin concentrations during selective decontamination of the digestive tract in intensive care unit patients on continuous venovenous hemofiltration</article-title>
          <source>Intensive Care Med</source>
          <year>2008</year>
          <volume>34</volume>
          <fpage>903</fpage>
          <lpage>906</lpage>
          <pub-id pub-id-type="doi">10.1007/s00134-008-1020-0</pub-id>
          <pub-id pub-id-type="pmid">18283433</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Posthouwer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Spronk</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Ros</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Rommes</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Absorption of tobramycin and amphotericin B during SDD in a patient with a bowel perforation</article-title>
          <source>Acta Anaesthesiol Scand</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>412</fpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-6576.2008.01856.x</pub-id>
          <pub-id pub-id-type="pmid">19243341</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miranda</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Schimmel</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Mimms</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Spinelli</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Driscoll</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Gentamicin absorption during prophylactic use for necrotizing enterocolitis</article-title>
          <source>Dev Pharmacol Ther</source>
          <year>1984</year>
          <volume>7</volume>
          <fpage>303</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">6478984</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Di</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Decorti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Malusa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ventura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Not</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Fasting increases tobramycin oral absorption in mice</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>1644</fpage>
          <lpage>1646</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.01172-09</pub-id>
          <pub-id pub-id-type="pmid">20086144</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
